This content is machine translated Fibrosis (FIB)-4 score Screening at-risk patients for NAFLD Non-alcoholic fatty liver disease (NAFLD) is the predominant cause of chronic liver disease. The FIB-4 score can be used to identify at-risk patients with NAFLD and, if necessary, refer them…
View Post 5 min This content is machine translated Non-alcoholic fatty liver disease (NAFLD) What does the current guideline say? Non-alcoholic fatty liver disease is the most common liver disease worldwide. The German S2k guideline, updated in 2022, recommends screening patients at risk. The proposed screening algorithm includes fibrosis assessment…
View Post 6 min This content is machine translated Roundtable discussion Use of conventional NSAIDs and coxibs in high-risk patients. Conventional NSAIDs and coxibs differ in their risk profile and tolerability, which is particularly important to consider in high-risk patients. But how to proceed? HAUSARZT PRAXIS in conversation with four…